By Simonelli Valeria; Leuzzi Giuseppe; Basile Giorgia; D'Errico Mariarosaria; Fortini Paola; Franchitto Annapaola; Parlanti Eleonora;…
By Piras Monica; Testa Andrea; Fleming Ian N; Dall’Angelo Sergio; Andriu Alexandra; Zanda Matteo; Menta Sergio; Menta Sergio; Mori Mattia; Brown Gavin D; et al
From ChemMedChem (2017), 12(14), 1142-1151, Language: English, Database: MEDLINE
Nonpeptidic Arg-Gly-Asp (RGD)-mimic ligands were designed and synthesized by click chemistry between an arginine-azide mimic and an aspartic acid-alkyne mimic. Some of these molecules combine excellent in vitro properties (high αv β3 affinity, selectivity, drug-like logD, high metabolic stability) with a variety of radiolabeling options (e.g., tritium and fluorine-18, plus compatibility with radio-iodination), not requiring the use of chelators or prosthetic groups. The binding mode of the resulting triazole RGD mimics to αv β3 or αIIb β3 receptors was investigated by molecular modeling simulations. Lead compound 12 was successfully radiofluorinated and used for in vivo positron emission tomography/computed tomography (PET/CT) studies in U87 tumor models, which showed only modest tumor uptake and retention, owing to rapid excretion. These results demonstrate that the novel click RGD mimics are excellent radiolabeled probes for in vitro and cell-based studies on αv β3 integrin, whereas further optimization of their pharmacokinetic and dynamic profiles is necessary for successful use in in vivo imaging.